- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 5/00 - Peptides having up to four amino acids in a fully defined sequenceDerivatives thereof
Patent holdings for IPC class C07K 5/00
Total number of patents in this class: 951
10-year publication summary
|
54
|
50
|
41
|
26
|
26
|
14
|
14
|
13
|
5
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 20506 |
23 |
| Protagonist Therapeutics, Inc. | 151 |
10 |
| Centre National de La Recherche Scientifique | 10870 |
9 |
| Massachusetts Institute of Technology | 10196 |
8 |
| Northwestern University | 3501 |
8 |
| The University of British Columbia | 1530 |
8 |
| Bicyclerd Limited | 147 |
8 |
| Novartis AG | 10350 |
7 |
| The Johns Hopkins University | 5813 |
7 |
| Arrowhead Pharmaceuticals, Inc. | 336 |
7 |
| Onyx Therapeutics, Inc. | 67 |
7 |
| Wisconsin Alumni Research Foundation | 3914 |
6 |
| The General Hospital Corporation | 4803 |
6 |
| Adocia | 145 |
6 |
| Emulate, Inc. | 195 |
6 |
| Oncotherapy Science, Inc. | 246 |
6 |
| President and Fellows of Harvard College | 6040 |
5 |
| Purdue Research Foundation | 3839 |
5 |
| Academia Sinica | 953 |
5 |
| Dana-Farber Cancer Institute, Inc. | 2630 |
5 |
| Other owners | 799 |